Spyre Therapeutics (SYRE) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 657.00 |
| Dec 31, 2025 | 896.00 |
| Sep 30, 2025 | 8.00 |
| Jun 30, 2025 | -367.00 |
| Mar 31, 2025 | 392.00 |
| Dec 31, 2024 | 681.00 |
| Sep 30, 2024 | -1,656.00 |
| Jun 30, 2024 | 3,742.00 |
| Mar 31, 2024 | 2,694.00 |
| Dec 31, 2023 | 1,952.00 |
| Sep 30, 2023 | -37,577.00 |
| Jun 30, 2023 | 41,736.00 |
| Mar 31, 2023 | -3,388.00 |
| Dec 31, 2022 | -2,146.00 |
| Sep 30, 2022 | 513.00 |
| Jun 30, 2022 | -2,121.00 |
| Mar 31, 2022 | -2,349.00 |
| Dec 31, 2021 | -827.00 |
| Sep 30, 2021 | -895.00 |
| Jun 30, 2021 | 1,307.00 |
| Mar 31, 2021 | -463.00 |
| Dec 31, 2020 | -354.00 |
| Sep 30, 2020 | 2,844.00 |
| Jun 30, 2020 | 6,152.00 |
| Mar 31, 2020 | -3,410.00 |
| Dec 31, 2019 | -3,068.00 |
| Sep 30, 2019 | -2,091.00 |
| Jun 30, 2019 | 206.00 |
| Mar 31, 2019 | 1,065.00 |
| Dec 31, 2018 | -1,663.00 |
| Sep 30, 2018 | 144.00 |
| Jun 30, 2018 | 718.00 |
| Mar 31, 2018 | -1,018.00 |
| Dec 31, 2017 | -744.00 |
| Sep 30, 2017 | -347.00 |
| Jun 30, 2017 | -233.00 |
| Mar 31, 2017 | -592.00 |
| Dec 31, 2016 | -466.00 |
| Sep 30, 2016 | 420.00 |
| Jun 30, 2016 | 737.00 |